Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
08/2005
08/10/2005CN1652779A Treatment of chemokine mediated diseases
08/10/2005CN1652759A Small molecule entry inhibitors
08/10/2005CN1651414A Separation and purification method of pyriproxyfen
08/10/2005CN1214027C Method for obtaining derivatives of [[(pyridil substituted) methyl] thio] benzimidazol
08/10/2005CN1214022C Vitamin D analogues
08/10/2005CN1214008C Therapeutic biaryl derivatives
08/10/2005CN1213989C New polymerisable liquid crystalline compounds
08/10/2005CN1213980C Vitamin D analogues
08/10/2005CN1213658C Picolinamide derivatives and pest controllers containing same as active ingredient
08/09/2005US6927225 Fungicidal 2-pyridyl alkyl amides and their compositions, methods of use and preparation
08/09/2005CA2327029C Method for making 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinoline
08/09/2005CA2199786C Process for the preparation of arylamides of heteroaromatic carboxylic acids
08/09/2005CA2189705C Use of flupirtine for the prophylaxis and therapy of diseases associated with an impairment of the haematopoetic cell system
08/09/2005CA2188164C Benzamide compounds and pharmaceutical use thereof
08/09/2005CA2164690C Method for safening herbicides in cereal crops using 5-aryloxy-1, 2-(disubstituted)benzene compounds
08/04/2005WO2005071145A1 Dast twin crystal, process for producing the same and use thereof
08/04/2005WO2005070934A1 Substituted diazabicycloheptanes and their use as protein kinase inhibitors
08/04/2005WO2005070910A2 Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and use of same as inhibitors of the faah enzyme
08/04/2005WO2005070891A2 Compounds and methods of use
08/04/2005WO2005070889A1 Herbicidal amides
08/04/2005WO2005070888A2 Process for the manufacture of 2,3-dichloropyridine
08/04/2005WO2005070877A1 Diamino alcohols and their use as renin inhibitors
08/04/2005WO2005070856A1 Octahydronaphthalene derivative and medicine
08/04/2005WO2005070853A1 Method of deuteration using mixed catalyst
08/04/2005WO2005054179A3 Hydroxamic acid esters and pharmaceutical use thereof
08/04/2005WO2005040355A3 Tao kinase modulators and methods of use
08/04/2005WO2005034867A3 Thioether-substituted benzamides as inhibitors of factor xa
08/04/2005WO2005018557A3 Substituted pyridinones
08/04/2005WO2005005376A3 Fungicidal phenoxyphenylhydrazine derivatives
08/04/2005WO2005000804A3 Substituted indoles and a process for preparing substituted indoles
08/04/2005WO2004092135A3 Substituted benzosulphonamide as potentiators of glutamate receptors
08/04/2005WO2004046324A3 Allele-targeted rna interference
08/04/2005WO2004007457A3 Substituted benzylamine derivatives and methods of use
08/04/2005US20050171366 Forming a diastereoselective epoxide from a chiral alpha-amino aldehyde; efficient synthesis of intermediates which are readily amenable to the large scale preparation of hydroxyethylurea-based chiral HIV protease inhibitors
08/04/2005US20050171355 important intermediate; without using an expensive catalyst and a special facilities; reacting a pyrimidinium derivative such as 1,3-dimethyl-2,3-dihydro-2-oxopyrimidinium chloride, an acetyl compound such as 4-acetylpyridine and an ammonia or an ammonium salt
08/04/2005US20050171181 Histamine-3 receptor modulators
08/04/2005US20050171163 MCP-1 receptor antagonists and methods of use thereof
08/04/2005US20050171154 Carboxylic acid amides
08/04/2005US20050171140 Prevent cholesterol biosynthesis; moderating blood serum lipid ; antidiabetic agents; obesity; hypotensive agents; osteoporosis; Alzheimer's disease; cardiovascular disorders; hormone replacement therapy
08/04/2005US20050171136 Modulators of the glucocorticoid receptor and method
08/04/2005US20050171115 conditions ameliorated by monoamine reuptake; vasomotor symptoms; 4-[1-(3-chlorophenyl)-2-piperazin-1-ylethyl]tetrahydro-2H-pyran-4-ol; antidepressantp; sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, fibromylagia syndrome; nervous system disorders
08/04/2005US20050171104 Novel thyroid receptor ligands
08/04/2005US20050171103 Benzamide derivatives useful as histone deacetylase inhibitors
08/04/2005US20050171102 Semicarbazide derivatives for combating thromboembolic diseases
08/04/2005US20050171097 aryl is nitrogen heterocycyl; highly effective at a low dose and excellent in safety; farm and garden pests; 2-(2-propenylthio)-4-(4-trifluoromethylphenyl)benzonitrile
08/04/2005US20050171085 Lactam-containing compounds and derivatives thereof as factor Xa inhibitors
08/04/2005US20050170529 Apparatus which utilizes fluoresence from europium chelates as detection tool in cell imaging, flow cytometry and immunohistochemistry assays
08/04/2005CA2553850A1 Process for the manufacture of 2,3-dichloropyridine
08/04/2005CA2553831A1 Diamino alcohols and their use as renin inhibitors
08/04/2005CA2553376A1 Method of deuteration using mixed catalyst
08/04/2005CA2553232A1 Substituted heterocyclic compounds and methods of use
08/03/2005EP1559711A1 Preparation of pyridine derivatives using pyrimidinium derivatives as intermediates
08/03/2005EP1559709A1 Heterocycle-containing carboxylic acid derivative and drug containing the same
08/03/2005EP1559320A1 3-benzoyl-2,4,5-substituted pyridine derivatives or salts thereof and bactericides containing the same
08/03/2005EP1558669A1 Electroluminescent metallo-supramolecules with terpyridine-based groups
08/03/2005EP1558606A2 Lactam-containing diaminoalkyl, beta-aminoacids, alpha-aminoacids and derivatives thereof as factor xa inhibitors
08/03/2005EP1558580A2 N-sulfonyl-4-methyleneamino-3-hydroxy-2-pyridones as antimicrobial agents
08/03/2005EP1558579A1 N-alkyl-4-methyleneamino-3-hydroxy-2-pyridones as antimicrobials
08/03/2005EP1558578A1 Novel alkyne compounds having an mch antagonistic effect and medicaments containing these compounds
08/03/2005EP1558567A1 Novel amide compounds with mch antagonistic effect and medicaments comprising said compounds
08/03/2005EP1436284B1 Synthesis of 4- (z)-(4-bromophenyl)(ethoxyimino)methyl]-1'- 2,4-dimethyl-1-oxido-3-pyridinyl)carbonyl]-4'methyl-1,4'bipiperidine
08/03/2005EP1016661B1 2,6-dichloro-4-pyridinemethanol derivatives as agricultural chemicals
08/03/2005EP0946550B1 PREPARATION OF [1S-[1a,2b,3b,4a(S*)]]-4-[7-[[1-(3-CHLORO-2-THIENYL)METHYL]PROPYL]AMINO]-3H-IMIDAZO[4,5-b]PYRIDIN-3-yl]-N-ETHYL-2,3-DIHYDROXYCYCLOPENTANECARBOXAMIDE
08/03/2005CN1650163A Artificial receptors, building blocks, and methods
08/03/2005CN1649886A Electroluminescent materials
08/03/2005CN1649885A Cellular accumulation of phosphonate analogs of HIV protease inhibitor compounds and the compounds as such
08/03/2005CN1649865A Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
08/03/2005CN1649859A Substituted phenylacetamides and their use as glucokinase activators
08/03/2005CN1649851A Method for producing substituted phenylsulfonyl urea
08/03/2005CN1649831A Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient
08/03/2005CN1649830A Substituted aryl ketones
08/03/2005CN1649829A Novel florfenicol-type antibiotics
08/03/2005CN1649827A Process for preparing highly functionalized gamma-butyrolactams and gamma-amino acids
08/03/2005CN1649820A Compounds that modulate PPAR activity and methods for their preparation
08/03/2005CN1649819A Novel thyroid receptor ligands
08/03/2005CN1649582A Amino-methyl substituted tetracycline compounds
08/03/2005CN1648200A Phenyl pyridine-iridium metal complex compounds for organic electroluminescent device, and organic electroluminescent device using the compounds
08/03/2005CN1213044C Amine and amide derivatives as ligands for neuropeptide YY5 receptor useful in treatment of obesity and other disorders
08/03/2005CN1213040C Serine protese inhibitors
08/03/2005CN1213038C Benzophenones as inhibitors of reverse transcriptase
08/03/2005CN1213031C Method for producing 5-aryl nicotinaldehydes
08/03/2005CN1213025C 硫代酰胺衍生物 Thioamide derivatives
08/03/2005CN1213022C Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas
08/03/2005CN1213021C N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl-3-substituted-alkyl, aryl or heteroarylamides) as matrix metallo protein inhibitors
08/03/2005CN1213020C Phenylalaninol derivatives
08/03/2005CN1213019C Sulfonamide and carboxamide derivatives and drugs containing same as active ingredient
08/03/2005CN1213018C Liquid crystal compounds
08/03/2005CN1213017C Propynyl or diene diaryl compounds
08/02/2005US6925388 Heterocyclic nonnucleoside inhibitors of reverse transcriptase
08/02/2005US6924392 Ortho, meta-substituted bisaryl compounds, processes for their preparation, their use as medicaments, and pharmaceutical preparations comprising them
08/02/2005US6924377 Etherifying mucochloric or mucobromic acid with an alcohol, alkylation, hydrogenation, dehydrochlorination or dehydrobromination, decyclization by reductive amination and carboxylation; 3-Aminomethyl-5-methyl-hexanoic acid
08/02/2005US6924314 Compounds for the treatment of metabolic disorders
08/02/2005US6924312 Taxol enhancer compounds
08/02/2005US6924301 Composition for treating or preventing arrhythmia
08/02/2005US6924300 Oxyiminoalkanoic acid derivatives
08/02/2005US6924286 Sulfur compounds such as phenylmethyl [2R-hydroxy-3-[(3-methylbutyl) (phenylsulfonyl)amino]-1S-(phenylmethyl)propyl]carbamate, used for prevention of viral diseases and replication
08/02/2005CA2243199C Novel 3,4-diaryl thiophenes and analogs thereof having use as antiinflammatory agents
08/02/2005CA2190087C Nitro compounds and their compositions having anti-inflammatory, analgesic and anti-thrombotic activities
08/02/2005CA2170020C Retroviral protease inhibiting compounds
07/2005
07/28/2005WO2005068457A1 Cataltytic asymmetric hetero diels-alder reaction of a heteroaromatic c-nitroso dienophile: a novel method for synthesis of chiral non-racemic amino alcohols
1 ... 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 ... 633